Become a Patient

February 25, 2003

Bacterial Infections Alter Allergic Response

Findings Support Hygiene Hypothesis

Researchers at National Jewish Medical and Research Center have gathered strong experimental support for the hygiene hypothesis, a proposed explanation for the worldwide rise in asthma and allergies. The research team, led by Richard Martin, MD, found that early infection with the bacterium Mycoplasma pneumoniae reduced a mouse's subsequent response to allergens. Alternatively, mice exposed to allergens prior to infection, developed a stronger allergic response. The research team is reporting its results in the March 2003 issue of the journal Infection and Immunity.

"For the first time, we have shown that a bacterial infection can modify the allergic response," said Dr. Martin, Vice Chair of the Department of Medicine at National Jewish. "Timing is everything, however. Our results suggest that M. pneumoniae, or a related pathogen, could help prevent asthma and other allergic diseases, but only if the infection occurs before a person is sensitized to an allergen."

Asthma and allergies have both been on the rise for several decades, especially in developed countries. The hygiene hypothesis has offered one explanation for this increase: compared with the past, children living in these countries today are exposed to fewer infectious organisms, which are necessary to properly train their developing immune systems. As a result, their immune systems overreact to relatively harmless irritants, leading to allergies and asthma.

So far, however, most evidence both for and against the hygiene hypothesis has been indirect and observational. The National Jewish research team sought more direct evidence using a mouse model of asthma and the bacterium M. pneumoniae, a common cause of community-acquired pneumonia.

In their study, Martin and his colleagues inoculated mice with either the bacterium or with a saline solution. Then all the mice were made allergic to the egg protein ovalbumin. Two weeks later, the mice were then exposed to the ovalbumin again, and their allergic response was evaluated.

On several measures, the mice that had been infected showed a milder reaction to the ovalbumin than did the control mice. Bronchial hyperresponsiveness (a measure of the "twitchiness" of the airways of these asthma-prone mice), levels of the cytokine IL-4, and total white cell count in the airways were all lower in the previously infected mice than in mice who were not infected. Levels of gamma interferon, which is associated with a healthy non-allergic immune response, were higher in the previously infected mice.

When mice were first sensitized and exposed to ovalbumin, then infected with bacteria, they showed greater bronchial hyperresponsiveness and airway inflammation than did control mice.

"Our results support the hygiene hypothesis," said lead author Hong Wei Chu, MD "Although mice are clearly different from humans, this kind of data, generated in a controlled experiment, adds important new evidence to help evaluate the hygiene hypothesis."

Note: This information is provided to you as an educational service of National Jewish Health. It is not meant to be a substitute for consulting with your own physician.

© Copyright 2008 National Jewish Health

National Jewish Health in the News

Exploring Personalized Medicine (Audio)
-- Colorado Public Radio

Teaming up to Fight Food Allergies
-- 9News

When the Workplace Makes You Sick
-- New York Times

Law Lightens Fear of Genetic Discrimination
-- Denver Post

Research Uncovers Clues to Lymphoma
-- U.S. News and World Report

Who's a Good (Germy) Boy?
-- Newsweek

Asthma and Allergies Could Start in the Womb
-- ABC News

New Directions Online

Read the latest issue of New Directions, a publication for friends of National Jewish Health. It includes news briefs, donor profiles, patient profiles and an ask the expert section.

Search Press Releases

  Go

Browse by Year 
2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996 

Media Contacts

William Allstetter 
Tel: (303) 398-1002 
Pager: (303) 281-1653 
E-mail: allstetterw@njc.org

Adam Dormuth
Tel: (303) 398-1082
Pager: (303) 851-0358
E-mail: dormutha@njc.org